ATP synthase subunit a is integral to bacterial energy metabolism and virulence:
Mitochondrial Manipulation: L. pneumophila effectors like Ceg3 (Lpg0080) ADP-ribosylate host ADP/ATP translocases (ANTs), disrupting mitochondrial ATP/ADP exchange to favor bacterial replication .
Host Cell Survival: The bacterium reverses mitochondrial FOF1-ATPase activity to ATP hydrolase mode, preserving host membrane potential (Δψm) and delaying apoptosis .
ADP-Ribosylation: Ceg3 modifies ANTs at a conserved arginine residue (within the -RRRMMM- motif), inhibiting mitochondrial ADP/ATP transport . This modification peaks 6–10 hours post-infection, correlating with maximal bacterial replication .
ATPase Activity: The DotB protein, a homolog of PilT ATPase, is essential for L. pneumophila’s type IV secretion system (T4SS). DotB hydrolyzes ATP (6.4 nmol/min/mg) to energize effector translocation .
V-ATPase Inhibition: Effector SidK targets host V-ATPase subunit VatA, neutralizing phagosome acidification to facilitate intracellular survival .
Transcriptional Regulation: The rsmYZ ncRNAs modulate CsrA activity, indirectly influencing atpB expression and bacterial virulence .
Recombinant atpB is utilized in:
Vaccine Development: As an antigen for antibody production (e.g., Creative Biolabs’ VAng-Lsx04273) .
ELISA and Binding Assays: Commercial kits (e.g., Anagnostics’ CSB-CF722933LAAB) detect atpB in pathogenicity studies .
Temporal Regulation: ADP-ribosylation of ANTs by Ceg3 is transient, suggesting dynamic effector interplay during infection .
Structural Dynamics: The noncanonical macrodomain of ARH Lpg0081 enables ADPr removal from ANTs, highlighting evolutionary adaptation .
KEGG: lpn:lpg1051
STRING: 272624.lpg1051